New balloon coated with drug could keep airways open longer

NCT ID NCT07191860

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a special balloon coated with the drug paclitaxel to treat benign (non-cancerous) narrowing of the windpipe or main breathing tubes. The balloon is inflated to open the airway, and the drug may help keep it open longer. About 200 adults with this condition will be randomly assigned to get either the drug-coated balloon or a standard uncoated balloon. The goal is to see if the drug-coated balloon reduces the need for repeat procedures.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
paclitaxel-coated balloon
What this could lead to
If it works, this could reduce how often patients need repeat procedures to open a narrowed airway, improving their quality of life.
What could go wrong
This is a relatively early-stage trial with 200 participants. The drug-coated balloon may not work better than standard treatment, and there are risks like bleeding, airway injury, or breathing problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADULT BENIGN CENTRAL AIRWAY STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Johns Hopkins University

    RECRUITING

    Baltimore, Maryland, 21218, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.